19 . 04 .2023
Press release
Augmented reality: patient experience trumps misconceptions around injectables
30 . 03 .2023
Press release
AMWC 2023: Data from Sculptra® Cheek Wrinkle and Alluzience® Star Studies reinforce strength of Galderma’s broad aesthetic portfolio
18 . 03 .2023
Press release
AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis
13 . 03 .2023
Press release
Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
26 . 01 .2023
Press release
Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
23 . 01 .2023
Press release
Galderma expands footprint with new Global Capability Center in Barcelona to support global growth
20 . 01 .2023
Press release
IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio
13 . 10 .2022
Press release
Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific
16 . 09 .2022
Press release
Galderma debuts the Sensitive Skincare Faculty, a global expert group to improve understanding and management of sensitive skin
06 . 09 .2022
Press release
Galderma showcases its continued commitment to innovation in dermatology with new data to be presented at 2022 EADV congress